Nmc Health Dividends - NMC

Nmc Health Dividends - NMC

Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Nmc Health Plc NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  9.00 0.34% 2,640.00 2,675.00 2,567.00 2,624.00 2,631.00 16:35:26
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Nmc Health NMC Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
07/03/2019FinalGBX18.131/12/201731/12/201813/06/201914/06/201910/07/201918.1
07/03/2018FinalGBX10.631/12/201631/12/201714/06/201815/06/201810/07/201810.6
08/03/2017FinalGBX10.631/12/201531/12/201611/05/201712/05/201702/06/201710.6
14/03/2016FinalGBX6.231/12/201431/12/201519/05/201620/05/201620/06/20166.2
20/05/2015FinalGBX5.431/12/201331/12/201428/05/201529/05/201525/06/20155.4
25/02/2014FinalGBX4.431/12/201231/12/201328/05/201430/05/201403/07/20144.4
26/02/2013FinalGBX4.131/12/201131/12/201229/05/201331/05/201304/07/20134.1

Top Dividend Posts

DateSubject
18/10/2019
14:53
aquaesulis01: CMD was on the 22nd Oct last year and made quite a difference to the share price over the following week (from £30 to £35) supported by quite a comprehensive presentation posted on the NMC website, hope for more of the same Monday.
19/9/2019
09:03
steeplejack: https://shorttracker.co.uk/company/GB00B7FC0762/ Yes AQR are looking to slide out the back door.I can’t see that they’re banking a profit on these most recent trades. Analysts at Berenberg raised their target price on healthcare provider NMC Health from £36 to £40 on Wednesday (18 Sept)stating that its bear case was "going into hibernation" following the group's recent first-half results. Berenberg said NMC's interim results brought with them an inflexion point for the group's shares and argued that persistently strong fundamental trends had now come back into market focus, striking a positive chord with investors, while further diminishing the bear case. Strong fundamentals across the board were further supported by NMC announcing an opportunistic share buyback programme of up to $200m, which was intended to capitalise on what Berenberg, and the company, viewed as "a materially undervalued share price". "We increase our price target to £40.00 (from £36.00 previously), reflecting higher revenue expectations, improved cash dynamics and better visibility on the fundamental drivers," said the German bank. Berenberg also expects to see NMC's "impressive" momentum in organic growth for underlying earnings and revenues continue, pointing out that there was "little reason" why it should not sustain this performance in the "years to come". The analysts felt the company was about to enter "a new phase", shifting away from large-scale mergers and acquisition in order to focus on integrating its acquired businesses and maturing operational beds, which they expect to drive margin expansion and support further double-digit top-line growth. "We believe this shift in focus will continue to be appreciated by the market, lowering the risk profile of the business, allowing for improved cash dynamics and enabling the underlying business to accelerate on the back of previous CAPEX investments," said Berenberg. Feedback
27/8/2019
18:19
mohdusman44: The functions that I would like see a great improvement within NMC is its PR and IR team. Both these departments seems not upto the mark during the share price fall. Nmc could have handled and arrested the share price fall aided by shorts and post the Muddywater episode in a much better and effective manner preventing the share price from nosediving. Investors were clueless and in a panic mode. A proper communique on a timely manner plus a good PR would have avoided this situation wherein investors ended burning their fingers.
27/8/2019
13:36
mohdusman44: @Alexak1, keeping a close watch at what price the company will be doing the buy backs. Looks like this time, NMC share price will beat TP recommended by the Analysts. As NMC's CEO rightly commented in its HY results announcement, there is big disconnect between fundamentals and valuation which is bound to get corrected soon. The stock should be somewhere around gbp 2500, by the time the management is done with its road shows covering multi-continents.
22/8/2019
06:45
edmondj: steeplejack, Stake-sellers probably would not get 'peak price' although £40 was in a pretty tight, public market susceptible to trends. Price for normal market size versus double-digit % stakes, being quite different and considered/negotiated. Off the top of my head I can't recall the extent of premiums, Chinese companies have paid in M&A but obviously there's just been the example of 50% regarding Greene King. NMC's Middle East healthcare does look a logical expansion for Fosun despite things not going swimmingly at Thomas Cook. I.e. those who want long-term to crystalise at least some extent of their holdings may realistically respect, it may need the recent share price drop to attract a strategic buyer at all (thus negotiations e.g. in a £30-35/share area). Alternatively the bears may retort, if NMC is Fosun's next choice after Thomas Cook, 'says it all'! Though if the press plant is to be believed, 'two prospective buyers'.
14/8/2019
12:42
alexka1: Pls can you explain what is not transparent about NMC ? This is what short sellers want ppl to believe (are you one of them ? :) ). NMC uses top notch accountants and auditors (western ones, top 3) as you can see in their reports. I feel they have been transparent on acquisitions, prices, numbers and all. not sure what is lacking. it is a company that have been disclosing regularly numbers and issuing guidance, with a decent amount of analyst coverage. Share price has been acting crazy on the back of short sellers selling as you can clearly see in the short data of the FCA. obviously when a stock is thinly traded and every week since december a hedge fund short 0.10% of the company, this will create a downward momentum, coupled with some bad press focusing on the short sellers. I cant see any reasons for it to be that low and i am confident about company data, Also 2 analysts reaffirmed sit visits (GS and Barclays) last month and reiterated they are comfortable with numbers. So a HF based in the US has more clarity than analysts that have bee studying the stock, coordinating with management and doing site visits? also more clarity then its own insiders that have been buying shares?
10/8/2019
15:38
alexka1: Here is the CITI note published 2 days ago... as i said over 20% if short - this is the time to buy, its so crowded as a trade on no news. just ppl getting on a trade without reasons following the few big HFs and recent price slumps. NMC Health (NMC.L) Alert: Stock down >10% on no news, our thoughts... The NMC share price is 10-15% lower in afternoon trading, and we see no company-specific or industry news flow. We struggle to explain the move based on fundamentals but offer thoughts on what might be driving the shares weaker, however unjustified we think the move is: – Yesterday, NMC’s shares fell ~7% on no news flow as well: We believe that some investors might have drawn negative conclusions regarding NMC from a tweet by Muddy Waters Research about a new publication released on 7 August. The stock in this publication turned out to be Burford Capital Ltd (BURF.L, not rated), which today is trading ~50% lower. The knock-on effects of this severe move for Burford could be impacting NMC’s share price (on risk aversion). – The influence of the shorts could be accentuating these moves: >20% of NMC’s float is shorted currently, and a large portion of the short positions are at momentum funds, which could be compounding the price action. With Monday’s positive development of the partial removal of pledged stock by insiders, some active shorts may see time as running out for the forced selling to be triggered related to pledged stock (see NMC Health - Partial pledge removal). Total removal of the pledge would dent the bear case, in our view. Active shorts might be opportunistically aggressive in their selling now. – Lack of buyers to step in is concerning, to us: We are surprised that NMC bulls didn’t see good enough value or have high enough conviction in the stock to apprehend a slide of this quantum. – We like the fundamental story and continue to rate NMC a Buy: Modest EPS cut, big TP cut to reflect new reality. Retain Buy. Citi Research Equities Health Care Facilities CEEMEA │ United Arab Emirates
08/8/2019
13:39
alexka1: Statement re. share price movement FROM NMC WEBSITE- TIME TO BUY ! ! ! NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, notes the recent share price weakness and confirms that it expects to report that, after a good performance in the first half of 2019, trading in the business remains in line with management expectations on all key metrics including revenue, EBITDA, net income, leverage, cash flow conversion and working capital. Full year guidance remains as previously stated. In accordance with accounting requirements, the Company will be reporting its interim results on a post-IFRS 16 basis but intends to also provide pre-IFRS 16 comparators for the purposes of those sell-side research analysts that continue to forecast the Company’s performance on such basis. The Company will be able to comment in further detail and will be reporting its interim results on 22 August 2019 in line with the statement released on Monday 5 August 2019.
08/8/2019
13:38
alexka1: News NMC Health Confirms "Good" Interim Performance Amid Share Price Fall (Alliance News) - Private healthcare operator NMC Health PLC confirmed Thursday the first half of ... Alliance News8 August, 2019 | 12:23PMEmail Form (Alliance News) - Private healthcare operator NMC Health PLC confirmed Thursday the first half of 2019 had delivered a "good" performance with trading in line with expectations. The Gulf-focused firm made the announcement after noting recent "share price weakness" since the start of August. Shares in NMC were 5.5% higher at 2,109.00 pence in London on Thursday, however shares have still shed 15% since the start of August. NMC emphasised performance over the six months ended June was "good" and that trading "remains in line with management expectations" on all key metrics including revenue, earnings before interest, taxes, depreciation & amortisation and leverage. Full year guidance also remains as previously stated.
07/8/2019
21:50
steeplejack: Yes,interesting.There seems to be massive oversupply. However....todayR17;s move as reported by Daily Telegraph: Louis Ashworth, markets reporter 7 AUGUST 2019 • 7:28PM Follow It may not have been the intended target, but NMC Health ended up as collateral damage from Muddy Waters Research’s attack on litigation funder Burford Capital. The Abu Dhabi-based hospital operator’s share ended off just over 11pc, having fallen 6pc on rumours it was the planned target of Muddy Waters’s report. A slide that began in the aftermath of Muddy Waters’s tweet teasing the report, which promised a release at “8am London time”, turned into a full-blown drop, dragging the company’s share price to a two-year low after a year of steady decline. It fell 258p to £20. Burford dropped catastrophically, by as much as 64pc, which resulted in billions of pounds being wiped off its share cap after... The FT carried the following observation: ● NMC Healthcare was the FTSE 100’s sharpest faller, with the United Arab Emirates hospital operator hitting a two-year low. Barclays analysts said they had received “numerous questions” from clients about NMC on Tuesday after Muddy Waters tweeted to tease its research without naming the target. “We believe accounting concerns are misplaced and . . . see an increasing disconnect between fundamentals and valuation at a company with a demonstrable track record in execution,” the broker said of NMC.
Your Recent History
LSE
NMC
Nmc Health
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191024 04:03:52